← Back
Data updated: Mar 10, 2026
THEA PHARMA
CardiovascularOphthalmologyInfectious Disease
THEA PHARMA is a specialty pharmaceutical company focused on Cardiovascular, Ophthalmology, Infectious Disease. Key products include COSOPT PF.
1995
Since
8
Drugs
-
Trials
4
Approved (2yr)
Key Drugs
Recent Activity
AKTEN 2025-11-21
Labeling
ZOLYMBUS 2025-09-09
Type 3 - New Dosage Form
IYUZEH 2024-09-16
Labeling
AZASITE 2024-07-25
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 44%
4 drugs
Ophthalmology 44%
4 drugs
Infectious Disease 11%
1 drugs
Pipeline Strength Pro
Loading...
Competitors Pro
Baxter specialty
Infectious Disease, Cardiovascular, Ophthalmology
B BRAUN specialty
Infectious Disease, Ophthalmology, Cardiovascular
BAUSCH AND LOMB specialty
Ophthalmology, Cardiovascular, Infectious Disease
FOUGERA PHARMS other
Ophthalmology, Infectious Disease, Cardiovascular
Novartis big-pharma
Cardiovascular, Ophthalmology